It can lower blood viscosity significantly.
还能显著地降低血液粘度。
It was also noted that the decoction could lower blood viscosity, promote fibrinolytic activity and improve lipid metabolism.
同时观察到“镇眩汤”可以降低血黏度，促进纤溶活性，改善脂质代谢。
Conclusion: KXT can improve myocardial blood supply, protect myocardial injury, raise antioxidation ability, lower blood viscosity and increase myocardial volume of blood flow.
结论克心痛滴鼻剂可改善心肌供血，防治心肌损伤，提高抗氧化能力，降低血液粘稠度，增加心肌血流量，从而起到防治冠心病心绞痛的作用。
Conclusion: Ginseng and Strobal Injection combined with Sodium Nitroprusside could improve blood gas condition, lower blood viscosity, lower pulmonary artery pressure and improve heart function.
结论：参附注射液联合硝普钠，能改善血气状态，降低血液粘稠度，降低肺动脉压，改善心功能。
Ahylysantinfarctase from snake venom extract with lower fibrinogen and blood viscosity of the material.
蝮蛇抗栓酶从蝮蛇蛇毒提取的具有降低纤维蛋白原和血液粘滞度的物质。
Blood rheology:After voyage, whole blood viscosity and plasma viscosity in taken group were lower while RBC electrophoresis time was higher than those in non-taken group(P<0.05);
血液流变学：用药组航后全血粘度、血浆粘度均低于而红细胞电泳时间高于未用药组（P< 0 .0 5 ） ；
Conclusion Puerarin injection can lower the blood lipids, improve blood viscosity, and decrease urine protein.
结论葛根素注射液有较好的调节血脂、改善血粘度及降低尿蛋白排泄率的作用。
The main reasons of the increase in neonatal viscosity of blood are that hematocrit is higher, deformation of RBC is lower and aggregation of RBC is higher in newborn.
新生儿血液粘度增高的主要原因是由于血球压积较高，红细胞变形性较低而聚集性较高。
The result showed that the whole blood viscosity, hematocrit and erythrocyte sedimentation rate of the Rhizoma sparganii group were obviously lower than those of the blank control group (P<0.01).
结果表明：三棱组的全血粘度、血细胞压积以及血沉速率与空白对照组相比均有明显减小（P＜0．01）。
The mean speed of blood flow in MCA, the mean blood viscosity and erythrocyte deformity index at 3to 7days were lower than those in the control group(P<0.05).
纳洛酮组第3～7天内的MCA的平均血流速度、平均全血黏稠度和红细胞变形指数皆低于对照组（P<0.05）；
In the end of 6 weeks, platelet aggregability, blood viscosity, fibrinogen and HCT were prominently lower than in before therapy. It could maintain the therapy efficacy in the end of 12 weeks.
结果对照组第12周末较治疗前全血粘度、红细胞压积显著降低，培达组第6周末较治疗前血小板聚集率、全血粘度、纤维蛋白原、红细胞压积即有显著降低，第12周末能维持此疗效。
In the end of 6 weeks, platelet aggregability, blood viscosity, fibrinogen and HCT were prominently lower than in before therapy. It could maintain the therapy efficacy in the end of 12 weeks.
结果对照组第12周末较治疗前全血粘度、红细胞压积显著降低，培达组第6周末较治疗前血小板聚集率、全血粘度、纤维蛋白原、红细胞压积即有显著降低，第12周末能维持此疗效。
应用推荐